charcot f
charcot f
Disease
Presented by Maliha Arije
1
Introduction
2
Understanding Charcot-Marie-
Tooth Disease
• Charcot-Marie-Tooth (CMT) is a group of hereditary neurological
disorders.
• Also known as
• affect the peripheral nerves, leading to muscle weakness, sensation
loss, and other debilitating symptoms
• It is named after the three physicians who first described it in 1886:
• Jean-Martin Charcot, Pierre Marie, and Howard Henry Tooth.
3
Conti…
• large heterogeneous groups of sensory, neurological genetic disorders
• characterized by sensory neuropathies, muscular atrophies, abnormal
sensory conduction velocities, and ataxia
• Tooth (CMT) disease is the most common hereditary neuromuscular
disorder.
• with a prevalence of approximately 1 in 2,500 people
• It typically appears in the first two decades of life.
4
Symptoms and progression of CMT
1 Early Symptoms
CMT often starts with subtle symptoms like muscle weakness and atrophy
in the feet and lower legs, leading to difficulties with balance and walking.
2 Progressive Weakening
Over time, the muscle weakness can spread to the hands and upper limbs,
making daily tasks like buttoning shirts or opening jars increasingly
challenging.
3 Sensory Impairment
Many CMT patients also experience reduced sensation in the extremities,
leading to a higher risk of foot sores and injuries that go unnoticed.
Sign and symptoms
6
Causes
• (CMT) is caused by mutations in genes that cause the peripheral nerves to become
damaged.
9
Conti….
2 Symptom Onset
Patients with CMT1 typically notice the first symptoms, such as sensory loss
and muscle weakness, in adolescence.
3 Subtypes
CMT1 includes several subtypes, including CMT1A, CMT1B, CMT1C,
CMT1D, and CMT1E, each with distinct genetic causes.
CMT2: Axonal Defects
Genetic Basis
Symptom Onset
CMT3, also known as
Dejerine-Sottas Disease, CMT3 is associated with
is caused by specific point severe symptoms that
mutations in the P0 or typically present in
PMP-22 genes. infancy or early
childhood.
Disability
Patients with CMT3 are more likely to eventually lose the ability to walk independently.
CMT4: Severe Myelin Defec
Genetic Basis
CMT4 is caused by gene mutations that lead to
changes in the myelin sheath, similar to CMT3.
Symptom Onset
CMT4 is also associated with severe symptoms that
present in early childhood.
Subtypes
CMT4 includes several subtypes, each with a distinct
genetic cause, such as CMT4A, CMT4B, and CMT4C.
CMTX: X-Linked CMT
16
Treatment options
Othropedic Physical
Medication
devices therapy
17
Conclusion
Charcot-Marie-Tooth is not a fatal disease, and most people live to a
normal age and remain active and most patients live a normal lifespan
with proper management. It does not affect brain
18
References
•Alcantara, M., Portugal, D., & Oliveira, L. (2014). P234: Autosomal dominant intermediate Charcot-
Marie-Tooth disease and nephropathy: clinical presentation and long-term follow-up. Clinical
Neurophysiology, 125, S110-S111. https://doi.org/10.1016/s1388-2457(14)50362-8
•Banchs, I., Casasnovas, C., Albertí, A., De Jorge, L., Povedano, M., Montero, J., Martínez-Matos, J.
A., & Volpini, V. (2009). Diagnosis of Charcot-Marie-Tooth disease. Journal of Biomedicine and
Biotechnology, 2009, 1-10. https://doi.org/10.1155/2009/985415
•Charcot-Marie-Tooth disease - Causes. (2019, February 28). nhs.uk.
https://www.nhs.uk/conditions/charcot-marie-tooth-disease/causes/#:~:text=Charcot-Marie-Tooth
%20disease%20(,(
the%20central%2
•Charcot-Marie-Tooth disease types. (2022, November 8). News-Medical. https://www.news-
medical.net/health/Charcot-Marie-Tooth-Disease-Types.aspx
19
20